Organization
University of Oklahoma Stephenson Cancer Center
14 abstracts
Abstract
Lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) with salvage chemotherapy (CT) followed by autologous stem cell transplantation (ASCT) as second-line (2L) treatment in patients (pt) with R/R large B-cell lymphoma (LBCL): 3-year follow-up (FU) from the randomized, phase 3 TRANSFORM study.Org: University of Oklahoma Stephenson Cancer Center,
Abstract
Longitudinal changes in patient-reported outcomes (PROs) among early phase cancer clinical trial (EP-CT) participants.Org: Henri and Belinda Termeer Center for Targeted Therapies, Massachusetts General Hospital, Boston, MA, USA, Massachusetts General Hospital, Brigham and Women's Hospital/Massachusetts General Hospital, Massachusetts General Hospital Cancer Center, Surgical Oncology, Boston, MA, University of Oklahoma Health Sciences Center,
Abstract
Coping strategies and patient-reported outcomes (PROs) in early-phase cancer clinical trial (EP-CT) participants.Org: Henri and Belinda Termeer Center for Targeted Therapies, Massachusetts General Hospital, Boston, MA, USA, Massachusetts General Hospital, University of Oklahoma Health Sciences Center, Brigham and Women's Hospital/Massachusetts General Hospital, University of Oklahoma Stephenson Cancer Center,
Abstract
Safety and feasibility of outpatient CAR-T therapy: A single center analysis.Org: University of Oklahoma Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma University Health Sciences Center, University of Oklahoma Health Sciences Center, University of Oklahoma, Stephenson Cancer Center,
Abstract
Costs and access barriers to ondansetron: A national analysis of Medicare part D and Medicare Advantage plans.Org: Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, Dallas, TX, UT Southwestern Medical Center,
Abstract
Association between inpatient clinical nursing acuity and 30-day rehospitalization among hospitalized patients with advanced cancer.Org: Massachusetts General Hospital, Harvard Medical School, University of Oklahoma Stephenson Cancer Center,
Abstract
Patient-reported hope, prognostic understanding, quality of life, symptom burden, coping mechanisms, and financial wellbeing in early phase clinical trial participants.Org: Massachusetts General Hospital, Brigham & Women's Hospital, Division of Palliative Care and Geriatric Medicine, Florida State University, City of Hope Medical Center,
Abstract
Financial toxicity, quality of life, symptom burden, and access to resources in early-phase clinical trial (EP-CT) participants.Org: Massachusetts General Hospital, Brigham & Women's Hospital, Division of Palliative Care and Geriatric Medicine, Florida State University, City of Hope Medical Center,
Abstract
National survey of financial burdens and experience among patients with cancer receiving charitable co-pay assistance.Org: Massachusetts General Hospital, Fox Chase Cancer Center, Temple University Health System, HealthWell Foundation, University of North Carolina at Chapel Hill,
Abstract
Using telehealth to conduct serious illness conversations (SIC) for patients with metastatic lung cancer during the COVID-19 pandemic.Org: Massachusetts General Hospital, Harvard University, University of California Irvine, Dana-Farber Cancer Institute, University of Oklahoma Stephenson Cancer Center,
Abstract
A phase 2/3 trial in progress on tebentafusp as monotherapy and in combination with pembrolizumab in HLA-A*02:01+ patients with previously treated advanced non-uveal melanoma (TEBE-AM).Org: UPMC Hillman Cancer Center, University of Oklahoma Stephenson Cancer Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Cancer Center at Thomas Jefferson University,
Abstract
Beyond transportation: Financial hardship, food insecurity, and care access barriers among US cancer survivors with transportation barriers to care.Org: Roswell Park Comprehensive Cancer Center, Buffalo, NY, American Cancer Society, Atlanta, GA, Case Comprehensive Cancer Center,
Abstract
“It’s been a long journey:” A qualitative study of patient and caregiver experiences during multimodality treatment for locally advanced rectal cancer.Org: Massachusetts General Hospital, Department of Medicine, Icahn School of Medicine at Mount Sinai, Division of Hematology & Oncology, Harvard Medical School, University of Oklahoma Stephenson Cancer Center,
Abstract
ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma.Org: University Hospitals Leuven, Leuven, Belgium, Leuven Cancer Institute, BGOG, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark, Copenhagen University Hospital,